Sleep Apnea Devices Market by Segments (Sleep Apnea Therapeutic Devices, Sleep Apnea Diagnostic Devices) - Global Forecast to 2019 Released On 17th April 2015
The global sleep apnea devices market is expected to grow at a CAGR of 16.6% during the forecast period of 2014 to 2019. North America is the largest market in the global sleep apnea devices market, with a market share of 51.8% as of 2013, followed by Europe and Asia. The largest share of the North American segment is associated with various driving forces, such as the increasing patient pool of sleep apnea in this region, increasing awareness level among patients and caregivers, and the availability of technologically advanced diagnostic and therapeutic devices. It is estimated that approximately 4% of men and 2% of women suffer from Obstructive Sleep Apnea (OSA) globally. Also, the rising prevalence of comorbidities (such as drug-resistant hypertension, congestive heart failure, Type 2 diabetes, and stroke, among others) ensures that the global sleep apnea patient pool will grow in the coming years. However, the inadequate reimbursement coverage and patient compliance are perceived to hinder the growth of this market during the forecast period, 2014 to 2019. In this report, the global sleep apnea devices market is broadly classified on the basis of segments, namely sleep apnea therapeutic devices and sleep apnea diagnostic devices. The sleep apnea therapeutic devices is further segmented based on types, into home sleep testing/portable monitoring, sleep labs, respiratory polygraphs, two-channel screening devices, single channel screening devices, and actigraphy systems. Similarly, the sleep apnea therapeutic devices market is segmented based on types, into Positive Airway Pressure (PAP) devices, masks, adaptive servo-ventilation, airway clearance systems, oxygen devices, and oral appliances. PAP devices segment is the highest contributor in the therapeutic devices market. Further, the global sleep apnea devices market is segmented based on the geographies into North America, Europe, Asia, and the Rest of the World (RoW). The North American segment dominated the global sleep apnea devices market in 2013, with a share of 51.8%. The major factors contributing to its dominance are the increasing prevalence of sleep apnea, rising awareness among patients and caregivers about sleep apnea, and the rising popularity of oral appliances, among others. According to the American Academy of Sleep Medicine, the number of accredited sleep labs that test for sleep disorder has quadrupled in the past decade, indicative of the increasing awareness levels in this region about sleep apnea. Europe is the second-largest market for sleep apnea devices, mainly due to the increasing usage of therapeutic devices, growing prevalence of cardiology disorders, increasing prevalence of comorbidities, and presence of well-equipped sleep laboratories. Asia is estimated to be the fastest-growing market in the sleep apnea devices industry as it is projected to grow at a CAGR of 17.7% during the forecast period of 2014 to 2019. The report has profiled the leading players of this market, along with the developments (New product launches, partnerships, agreements, collaborations, and joint ventures) done by the companies over the past few years and strategies adopted by them to sustain and strengthen their positions in the global sleep apnea devices market. Philips Respironics, a subsidiary of Philips Healthcare (Netherlands); ResMed (U.S.); Compumedics Limited (Australia); Carefusion Corporation (U.S.); Curative Medical, Inc. (U.S.); BMC Medical Co., Ltd. (China); Natus Medical Incorporated (U.S.); Fisher and Paykel Healthcare, Ltd. (New Zealand); DeVilbiss Healthcare (U.S.); Global Medical Holdings, LLC (U.S.); Itamar Medical, Ltd. (U.S.); and Weinmann Medical Devices GmbH & Co. KG (Germany), among others, are some of the key players engaged in this market.
Reasons To Buy the Report:...
Please join StudyMode to read the full document